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and sICH patients. In univariate analysis, high systolic BPV 
was associated with sICH (p = 0.03). A logistic regression 
model to predict ICH only found early CT findings (OR = 2.74, 
95% CI = 1.47–5.11, p  ! 0.01) as independently associated 
with ICH. Poor 3-month outcome was independently pre-
dicted by age (OR = 0.96, 95% CI = 0.94–0.97, p  ! 0.001), NI-
HSS on admission (OR = 0.84, 95% CI = 0.80–0.87, p  ! 0.001), 
ICH (OR = 0.29, 95% CI = 0.13–0.66, p  ! 0.01) and high sys-
tolic BPV (OR = 1.68, 95% CI = 1.05–2.69, p  ! 0.05).  Conclu-
sions: We demonstrate that high BPV in patients receiving 
IVT leads to poor outcome but does not increase the risk of 
ICH/sICH.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 After intravenous thrombolysis (IVT) in acute stroke, 
the development of hemorrhagic transformation (HT) 
and especially symptomatic intracerebral hemorrhage 
(sICH) are some of the most feared adverse events. Sev-
eral conditions are suggested to enhance the risk of HT/
sICH, including among others age  [1] , stroke severity 
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 Abstract 
 Background: The relevance of blood pressure variability 
(BPV) in the development of intracerebral hemorrhage (ICH) 
after intravenous thrombolysis (IVT) in acute stroke still re-
mains uncertain.  Methods: 427 consecutive patients treated 
with IVT in the years 2007–2009 were studied. Blood pres-
sure (BP) values were analyzed from admission to follow-up 
imaging scan and described as mean, maximum, minimum, 
standard deviation (SD), difference between maximum and 
minimum, successive variation (SV) and maximum SV. ICH 
was categorized based on radiologic criteria and symptom-
atic ICH (sICH) was defined as ICH plus worsening of the Na-
tional Institute of Health Stroke Scale by  6 4 points or lead-
ing to death. Three-month outcome was described by means 
of the modified Rankin Scale.  Results: We observed any ICH 
in 51 (11.9%) and sICH in 10 (2.3%) patients. Systolic and dia-
stolic BP profiles, including mean, maximum, minimum, SD, 
difference between maximum and minimum, SV and maxi-
mum SV, did not differ between ICH-negative, ICH-positive 
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Scale (NIHSS)  [2] , congestive heart failure  [1] , early in-
farct signs  [1, 3] , platelet count  [4] , serum glucose and 
diabetes  [5] , antithrombotics  [1] , time to treatment  [6] 
and elevated systolic blood pressure (BP)  [1, 7] . Blood 
pressure variability (BPV) – the variation of BP with 
time – is presumed to be a strong and independent pre-
dictor of stroke in general, potentially more powerful 
than the absolute BP levels  [8] . In addition, BPV was 
linked to stroke and development of HT and was dem-
onstrated to be independently associated with outcome 
and with development of HT during the first 7 days after 
IVT  [9, 10] . Furthermore, BPV seems to contribute to 
growth of diffusion-weighted imaging lesions and dete-
rioration of clinical course after IVT  [11] . Most recently, 
a study demonstrated that BPV enhances the risk of HT 
within 72 h after acute cerebral infarction independent-
ly of treatment with IVT  [12] . Besides, BPV was shown 
to influence short-term outcome after stroke by increas-
ing the rate of death and neurologic deterioration at day 
10 after stroke  [13] .
 In the present study, we aimed to investigate the effects 
of BPV on development of any intracerebral hemorrhage 
(ICH) and sICH and 3-month outcome after IVT in acute 
ischemic stroke. 
 Methods 
 From our consecutive local stroke database, we extracted data 
for all prospectively documented patients treated with recombi-
nant tissue plasminogen activator intravenously in the years 
2007–2009. Local standard operating procedures recommend BP 
to be measured using an automatic monitoring system (Infinity 
Delta, Draeger Medical Systems Inc.) before IVT, every 15 min for 
the first 2 h after the start of IVT and at least hourly thereafter 
until the follow-up imaging examination. Exceptions from this 
rule are patients with BP levels above 185/90 mm Hg where these 
intervals are shortened. In case of elevated BP before and after 
IVT, treatment with antihypertensives – usually urapidil (5–50 
mg i.v.) – is recommended in the standard operating procedures. 
BP levels are noted in the patient’s file, which is electronically ar-
chived after discharge. These documents formed the basis for our 
retrospective analysis of the BP levels. Baseline and demographic 
characteristics, cardiovascular risk factors, time intervals, admis-
sion and follow-up imaging scans, and stroke severity using the 
NIHSS were prospectively collected. All patients were reassessed 
after 3 months either during an outpatient visit or by a telephone 
interview using the modified Rankin Scale by an investigator not 
blinded to the IVT treatment but unaware of BP levels and BPV. 
A favorable outcome after 3 months was defined as a modified 
Rankin Scale score of less than 2.
 Early infarct signs were defined as parenchymal hypoattenu-
ation or loss of gray-white differentiation in the cortical ribbon or 
the basal ganglia and/or mass effect in the baseline CT due to an 
ischemic lesion. 
 A follow-up imaging scan was performed 20–36 h after IVT 
or immediately after clinical deterioration was diagnosed. If clin-
ical deterioration developed later, another scan was carried out; 
thus, later clinically relevant bleedings were also detected and col-
lected. New hyperdense brain lesions were counted as ICH, irre-
spective of the clinical consequences. According to the definition 
in the ECASS trials  [14] , the ICHs were grouped according to mor-
phological appearance. HT was defined as a petechial infarction, 
whereas HT1 presents small and HT2 more confluent petechiae. 
Parenchymal hematoma (PH) contributes to a hemorrhage with 
mass effect. PH1 was defined as hemorrhage ^ 30% of the infarct-
ed area with mild space occupying effect and PH2 130% of the 
infarcted area with significant space occupying effect, or clot re-
mote from infarcted area. sICH was defined according to the 
ECASS 2 definition (detection of blood plus NIHSS worsening by 
4 or more points or leading to death).
 The BP values were analyzed until follow-up imaging scan and 
are described as follows: mean, maximum, minimum, standard 
deviation (SD) and difference between maximum and minimum. 
To represent BPV of an individual, we used successive variation 
(SV) and maximum SV  [9] . SV is calculated as the square root of 
the average squared difference between two successive BP mea-
surements using the following equation: 
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 In contrast with the widely known sample SD, the SV address-
es the time sequence of measurements. Patients were grouped in 
high ( 1 median) and low ( ^  median) systolic and diastolic BPV.
 Due to the retrospective character of this study, the lack of 
treatment influence, and data being collected as part of national 
and international quality control programs, we did not apply for 
the vote of an ethics committee.
 Statistical Analysis 
 Normally distributed data are present as mean and SD and 
nonnormally distributed data as median and interquartile range 
or counts and percentages, respectively. Comparison between 
ICH-negative, ICH-positive and sICH according to baseline 
characteristics, risk factors for ICH and BP values as well as uni-
variate analysis of outcome parameters were conducted with one-
way ANOVA. All parameters showing significance in the uni-
variate analysis were tested in a multivariate logistic regression 
model to explore predictors for ICH and main outcome param-
eters. Due to the possible colinearity of tested variables, we ap-
plied a stepwise logistic regression model. The results were con-
sidered statistically significant when p  ! 0.05. For all statistical 
testing, we used the Statistical Package for Social Sciences (SPSS 
Inc., v. 16.0 for Windows). 
 Results 
 Among 427 patients treated with IVT in the years 
2007–2009, 51 (11.9%) patients had any ICH and 10 (2.3%) 
patients suffered from sICH. We observed HT1 in 14 
(3.3%), HT2 in 10 (2.3%), PH1 in 16 (3.7%), PH2 in 10 
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(2.3%) and subarachnoid hemorrhage in 1 (0.3%) of our 
patients.  Table  1 shows baseline characteristics and  ta-
ble 2 shows risk factors for any ICH and sICH and radio-
logical ICH types. The median frequency (interquartile 
range) of BP measurements until follow-up imaging scan 
was 21.5 (9) in ICH-negative, 20 (9) in ICH-positive and 
12.6 (15) in sICH patients. 
 Systolic and diastolic BP profiles, including mean, 
maximum, minimum, SD, difference between maximum 
and minimum, SV and maximum SV did not differ be-
tween ICH-negative, ICH-positive and sICH patients ( ta-
ble 3 ), with the exception of the minimum diastolic BP, 
showing significantly higher levels in ICH-positive than 
ICH-negative patients (p = 0.02).
 In univariate analysis of systolic and diastolic BP, 
each of them divided into groups of high and low BPV, 
we found an association between high systolic BPV and 
occurrence of sICH (p = 0.03). With regard to the 
3-month outcome, low systolic BPV was strongly related 
to independency (p  ! 0.001) and there was a trend of 
high systolic BPV being related to mortality (p = 0.07). 
Mortality was more frequent in patients with high dia-
stolic BPV (p = 0.04) and independency tended to ap-
pear more often in patients with low diastolic BPV (p = 
0.07) ( table 4 ).
 In a stepwise logistic regression model including all 
parameters showing a significant difference between 
ICH-positive and ICH-negative patients in univariate 
analysis (NIHSS on admission, early CT findings, plate-
lets, atrial fibrillation), neither systolic nor diastolic BPV 
predicts ICH. Only early CT findings remain an indepen-
dent risk factor for ICH in our patients (OR = 2.74, 95% 
CI = 1.47–5.11, p  ! 0.01) ( table 5 ). Because early infarct 
signs were the only parameter which was associated with 
sICH in univariate analysis, no multivariate analysis was 
performed. 
 The logistic regression model for the 3-month out-
come identified age (OR = 0.96, 95% CI = 0.94–0.97, p  ! 
0.001), NIHSS on admission (OR = 0.84, 95% CI = 0.80–
0.87, p  ! 0.001), ICH (OR = 0.29, 95% CI = 0.13–0.66, p  ! 
0.01) and high systolic BPV (OR = 1.68, 95% CI = 1.05–
2.69, p  ! 0.05) as independently associated with poor out-
come. Age (OR = 1.08, 95% CI = 1.05–1.12, p  ! 0.001), 
NIHSS on admission (OR = 1.10, 95% CI = 1.06–1.15, p  ! 
0.001) and ICH (OR = 2.88, 95% CI = 1.43–5.80, p  ! 0.01), 
but neither high systolic nor high diastolic BPV predicted 
mortality within 3 months ( table 6 ).
 Discussion 
 In this retrospective analysis of 427 consecutive pa-
tients treated with IVT, we report BP measurements until 
follow-up imaging scan in a range of 21 measurements 
per patient. First of all, we found no difference between 
BP levels in ICH-negative and ICH-positive patients. In 
contrast to a recently published study, we also found no 
difference in BPV between ICH-negative and ICH-posi-
Table 1.  Univariate analyses of baseline characteristics
Parameter ICH negative 
(n = 376; 88.1%)
ICH positive 
(n = 51; 11.9%)
p1 sICH
(n = 10; 2.3%)
p2
Age, years 72.7812.8 73.2811 0.83 74.9814.6 0.59
Female 195 (51.8) 25 (49.0) 0.70 8 (80) 0.08
Risk factors
Hypertension 303 (80.6) 41 (80.4) 0.99 10 (100) 0.13
Diabetes 91 (24.2) 10 (19.6) 0.50 3 (30) 0.66
Hypercholesterolemia 92 (24.5) 13 (25.5) 0.85 3 (30) 0.68
Atrial fibrillation 123 (32.7) 24 (47.1) 0.041 5 (50) 0.25
Nicotine use 66 (17.6) 8 (15.7) 0.77 1 (10) 0.55
Antiplatelet use 163 (43.4) 24 (47.1) 0.64 5 (50) 0.48
Anticoagulant use 21 (5.6) 4 (7.8) 0.52 0 0.47
Previous cardiovascular event 61 (16.2) 10 (19.6) 0.52 4 (40) 0.05
F igures are means 8 SD or numbers with percentages in parentheses. The figure in italics indicates statisti-
cal significance.
1 One-way ANOVA. 2 Comparison between no ICH and sICH. 
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Table 2.  Risk factors for ICH and sICH 
Parameter ICH negative 
(n = 376; 88.1%)
ICH positive 
(n = 51; 11.9%)
p1 sICH2 
(n = 10; 2.3%)
p3
Early infarct signs on CT4 (n = 394) 99 (n = 348; 28.4%) 24 (n = 46; 52.2%) 0.0011 6 (n = 10; 60%) 0.018
Time window, min 168.4 (102.8) 170.5 (94.4) 0.89 179.7 (55.5) 0.73
Congestive heart failure 87 (23.1%) 18 (35.3%) 0.06 5 (50%) 0.05
Platelets, /nl 263.5 (95.6) 233.3 (62.4) 0.028 246.7 (73.3) 0.58
Serum glucose, mg/dl 134.7 (47.7) 139.5 (44.4) 0.45 127.6 (29.9) 0.64
NIHSS on admission 10.5 (9) 14 (8) 0.015 15.5 (12) 0.47
Latency to follow-up imaging scan, h 20.6 (7.3) 21.3 (7.6) 0.42 9.7 (18.7) <0.001
Number of measured BP per patient 21.5 (9) 20 (9) 12.6 (15)
BP intervention 131 (34.8%) 21 (41.2%) 0.37 2 (20%) 0.33
ICH types
HT1 14 (3.3%)
HT2 10 (2.3%)
PH1 16 (3.7%)
PH2 10 (2.3%)
SAH 1 (0.3%)
sICH 10 (2.3%)2
F igures are mean with SD in parentheses or median with interquartile range in parentheses (see text) or numbers with percent-
ages in parentheses. The figures in italics indicate statistical significance. SAH = Subarachnoid hemorrhage.
1 One-way ANOVA. 2 ECASS 2 definition. 3 Comparison between ICH negative and sICH. 4 Thirty-three patients were treated based 
on MRI. 
Table 3.  Systolic and diastolic BP values and comparison between ICH negative, positive and sICH
Parameter ICH negative 
(n = 376)
ICH positive 
(n = 51)
p1 sICH 
(n = 10)
p2
SBP mean, mm Hg 147.21816.52 149.28815.66 0.40 151.33817.45 0.43
SBP max, mm Hg 179.97821.99 180.76820.16 0.81 182.6820.87 0.71
SBP min, mm Hg 117.79818.27 120.88818.83 0.29 127821.24 0.12
SBP SD, mm Hg 16.6685.74 16.685.79 0.98 18.9288.56 0.21
SBP max – min, mm Hg 62.18822.64 59.88822.6 0.50 55.6829.59 0.60
SBP SV 13.4784.63 14.2885.51 0.25 16.1487.94 0.08
SBP SV max, mm Hg 40.89815.99 40.14818.04 0.75 41.2823.64 0.95
DBP mean, mm Hg 74.8389.32 77.4189.29 0.06 75.13810.44 0.92
DBP max, mm Hg 99.39814.5 100.37812.02 0.65 94.9812.45 0.33
DBP min, mm Hg 55.20810.29 58.82810.89 0.02 60.5813.63 0.11
DBP SD, mm Hg 11.7683.79 12.0984.06 0.56 11.5685.89 0.87
DBP max – min, mm Hg 44.19815.33 41.55815.44 0.25 34.4819.65 0.05
DBP SV, mm Hg 9.5282.92 10.4084.60 0.06 10.4187.11 0.37
DBP SV max, mm Hg 30.35812.29 30.67812.39 0.86 25.4813.07 0.21
F igures are means 8 SD. The figures in italics indicate statistical significance. SBP = Systolic BP; DBP = diastolic BP.
1 One-way ANOVA. 2 Comparison between ICH negative and sICH. 
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tive patients and therefore we cannot confirm a relation 
between BPV and development of ICH or sICH which 
was suggested in this study  [12] . However, in agreement 
with Yong et al.  [9] , we report systolic BPV as a strong and 
independent predictor of the 3-month outcome after 
acute stroke and IVT. 
 There are some differences between our study and the 
study by Ko et al.  [12] which might partially explain these 
discrepancies: the number of patients who received IVT 
was nearly three times higher in our study (427 vs. 158), 
although the absolute number of patients was smaller. 
We exclusively report about patients receiving IVT; this 
might explain why the absolute BP levels are lower due 
to a more aggressive treatment of elevated BP levels in 
those patients (e.g. maximum systolic BP in ICH-positive 
patients 188.6 vs. 180.8 mm Hg, maximum diastolic BP 
in ICH-negative patients 113.7 vs. 99.4 mm Hg). How-
ever, this does not explain why SD values of systolic and 
diastolic BP are remarkably similar, i.e. 16.5 and 11.2 mm 
Hg in the study by Ko et al.  [12] and 16.7 and 11.8 mm 
Hg in ours. We observed BP values until control imaging 
scan – in a range of 24 h after admission – whereas Ko et 
al.  [12] obtained BP measurements during the first 72 h. 
During this period, our median frequency of BP mea-
surements was 21 as compared with 18 and thus we mon-
itored more BP levels in a shorter interval. Finally, in 
contrast to Ko et al.  [12] , we differentiate between radio-
logic types of ICH and especially between asymptomatic 
and symptomatic ones, because whether or not asymp-
tomatic ICH is of any clinical relevance is still doubtful 
 [15] . 
 Pathophysiological considerations concerning the im-
pact of BPV include that, on the one hand, a rapid in-
crease in BP could lead to rupture of blood vessels and 
Table 4.  Univariate analysis of patients with high and low variability of systolic and diastolic BP and occurrence of HT and sICH and 
outcome parameters
Parameter Systolic BP low 
variability3 (n = 213)
Systolic BP high 
variability4 (n = 214)
p5 Diastolic BP low 
variability3 (n = 213)
Diastolic BP high 
variability4 (n = 214)
p5
HT 26 (12.2%) 25 (11.7%) 0.87 24 (11.3%) 27 (12.6%) 0.67
sICH 3 (1.4%) 7 (3.3%) 0.03 4 (1.9%) 6 (2.8%) 0.53
Independency1 115 (53.9%) 79 (36.9%) <0.001 106 (49.8%) 88 (41.1%) 0.07
Mortality2 35 (16.4%) 50 (23.4) 0.07 34 (15.9%) 51 (23.8%) 0.04
T he figures in italics indicate statistical significance. 
1 mRS score ≤2 at day 90. 2 mRS score = 6 at day 90. 3 ≤ Median SD. 4 > Median SD. 5 One-way ANOVA.
Table 5.  Final stepwise logistic regression model to predict any 
ICH
Variable Odds ratio (95% CI) p1
NIHSS 0.13
Early CT findings 2.74 (1.47–5.11) 0.002
Atrial fibrillation 0.06
Platelets 0.06
Systolic BP low variability 0.49
1  One-way ANOVA.
Table 6.  Final stepwise logistic regression model to predict main 
outcome parameters
M ortality at day 90a Independency at day 90b
odds ratio 
(95 % CI)
p odds ratio 
(95% CI)
p
Age 1.08 
(1.05–1.12)
<0.001 0.96 
(0.94–0.97)
<0.001
NIHSS 1.10 
(1.06–1.15)
<0.001 0.84 
(0.80–0.87)
<0.001
ICH 2.88 
(1.43–5.80)
<0.01 0.29 
(0.13–0.66)
<0.01
Diastolic BP 
low variability
n.s.
Systolic BP low 
variability
1.68 
(1.05–2.69)
<0.05
a m RS score = 6. b mRS score ≤2.
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therefore to HT/ICH, and on the other hand a sudden de-
crease might cause a shortage of cerebral perfusion and 
thus could lead to a clinically relevant deterioration due 
to reduced perfusion of the penumbra. 
 All in all, it seems that low BPV is beneficial for long-
term outcome and to counteract high BPV might be a 
target to improve outcome in IVT-treated stroke patients. 
But whether BPV leads to development of ICH/sICH is 
still doubtful in our opinion, and thus the way BPV influ-
ences the outcome remains unclear. 
 As data from larger trials are still lacking due to the 
limited number of reported BP values, more data from 
single centers should be published to enable the perfor-
mance of a meta-analysis in the future.
 Conclusion 
 We demonstrate that high BPV in patients receiving 
IVT leads to poor outcome but does not increase the risk 
of ICH/sICH. 
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